Hello!! I think the announcements are GREAT. It’s huge to get the Malta Facility only 5 Companies got in - MGC the only Australian company. This opens the gates to Europe! With Cannepil first 100 Australian patients getting the first batch within weeks ($1,000,000 revenue) this opens the doors to Europe Epilepsy patients!
There’s 70,000 people in Australia that have this form of epilepsy, I believe 200,000 in Europe- Cannepil is cheaper than currents meds on the market AND I believe Germany is the first country to cover cannabis under medical plan. I’m sure Europe Union will follow the lead. If MGC only got 5% market share that’s 13,500 patients $135,000,000 a year revenue
They did issue more shares, but looks like they maybe going into a mutual fund or etf — they also had more buyers than shares!!
Good news is MGC is about maxed out on share issuance- when the pps starts rising they shouldn’t have any more capital raise
Lets hope Australia sees this as good news !!
News 
Market Data 
Discover 
